Prognostic value of systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)

被引：0
作者：
Teran Brage, E. [1 ]
Reguera Puertas, P. [1 ]
Campana-Diaz, E. [2 ]
Navarro Martin, M. [1 ]
Garcia Talavera, P. [2 ]
Rama Alonso, S. [2 ]
Lopez Gutierrez, A. [1 ]
Roldan Ruiz, J. [1 ]
Garijo Martinez, M. D. C. [1 ]
Morchon Araujo, D. [1 ]
Posado-Dominguez, L. [1 ]
Redondo Gonzalez, J. C. [1 ]
Diaz Sanchez, P. [1 ]
Pablo Martin, E. [1 ]
Felix, L. C. [1 ]
Lozano Mejorada, R. [1 ]
Fonseca Sanchez, E. [1 ]
机构：
[1] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain
[2] Univ Hosp Salamanca, Nucl Med Dept, Salamanca, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1163P
引用
收藏
页码：S758 / S759
页数：2
相关论文
共 50 条
  • [31] Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Neuroendocrine Tumors: How Effective and Safe Are They?
    Liotsou, T.
    Stefanoyiannis, A. P.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S725 - S726
  • [32] Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
    Camus, Baptiste
    Cottereau, Anne-Segolene
    Palmieri, Lola-Jade
    Dermine, Solene
    Tenenbaum, Florence
    Brezault, Catherine
    Coriat, Romain
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 18
  • [33] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Bodei, Lisa
    Kidd, Mark
    Prasad, Vikas
    Modlin, Irvin M.
    NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 : 198 - 215
  • [34] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Basu, Sandip
    Parghane, Rahul, V
    Kamaldeep
    Chakrabarty, Sudipta
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (05) : 447 - 464
  • [35] Peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET): A single institution experience in the USA
    Duan, H.
    Ferri, V.
    Kunz, P. L.
    Fisher, G. A.
    Moradi, F.
    Davidzon, G. A.
    Franc, B. L.
    Iagaru, A. H.
    Mari, C. Aparici
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S468 - S469
  • [36] Peptide receptor radionuclide therapy of neuroendocrine tumors
    Haug, A. R.
    Bartenstein, P.
    ONKOLOGE, 2011, 17 (07): : 602 - +
  • [37] Peptide Receptor Radionuclide Therapy (PRRT) a Novel Option as Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors: A Surgical Series
    Miotto, M.
    Nessi, C.
    Cingarlini, S.
    Severi, S.
    Paganelli, G.
    Malleo, G.
    D'Onofrio, M.
    Pea, A.
    Vincenzi, S.
    Scarpa, A.
    Salvia, R.
    Landoni, L.
    NEUROENDOCRINOLOGY, 2019, 108 : 254 - 254
  • [38] Real-world analysis of peptide receptor radionuclide therapy (PRRT) in the treatment of neuroendocrine tumors.
    Chau, Justin
    Yu, Nanmeng
    Bakeri, Hirva
    Menda, Yusuf
    Dillon, Joseph S.
    Chandrasekharan, Chandrikha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Safety in Patients With Neuroendocrine Tumors Receiving Telotristat Ethyl (TE) With Peptide Receptor Radionuclide Therapy (PRRT)
    Chauhan, A.
    Binder, P.
    Tesfaye, E.
    Seth, K.
    Lapuerta, P.
    PANCREAS, 2021, 50 (03) : 447 - 448
  • [40] Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)
    Marco Schiavo Lena
    Stefano Partelli
    Paola Castelli
    Valentina Andreasi
    Chanel Elisha Smart
    Eleonora Pisa
    Mirco Bartolomei
    Emilio Bertani
    Giuseppe Zamboni
    Massimo Falconi
    Claudio Doglioni
    Endocrine Pathology, 2020, 31 : 119 - 131
12345